HEPA
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA)
$12
About HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.22
52 Week Low
$0.03
Market cap
13.3M
Dividend yield
-
Volume
--
Avg. volume
29,721
P/E ratio
-.55
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.22
52 Week Low
$0.03
Market cap
13.3M
Dividend yield
-
Volume
--
Avg. volume
29,721
P/E ratio
-.55